[1] |
WANG Yu, CHEN Yan, HAN Yuanyuan, XU Qing, CHEN Shengyue, LYU Zhibo, LU Chuan, ZHENG Mingxin, ZHAO Xin.
Platelet-lymphocyte Ratio Predicts In-hospital Mortality in Elderly Patients with Acute Myocardial Infarction
[J]. Chinese General Practice, 2023, 26(33): 4137-4142.
|
[2] |
CHEN Xi, ZHANG Juan, LI Lin, ZHANG Jiaqi, WU Yaoli, GUO Hui, WANG Chaoqun.
Association between Physical Activity and Risk of All-cause Mortality in Middle-aged and Elderly People in China: a Prospective Cohort Study
[J]. Chinese General Practice, 2023, 26(31): 3890-3895.
|
[3] |
ZHANG Dongli, SHEN Chong, ZHANG Weichuan, CHEN Haibin, ZHAO Jianjun.
Efficacy and Safety of Programmed Death-1/Programmed Death-1 Ligand Inhibitors in the Treatment of Renal Cell Cancer: a Meta-analysis
[J]. Chinese General Practice, 2023, 26(30): 3815-3822.
|
[4] |
SU Guobin, LING Xitao, DUAN Ruolan, ZHANG La, XU Yuan, PENG Yu, HOU Haijing, LIU Xusheng, LU Fuhua.
Selection of Therapeutic Drugs for COVID-19 Infection in Adults with Chronic Kidney Disease Based on Medical Evidence
[J]. Chinese General Practice, 2023, 26(26): 3220-3229.
|
[5] |
CHEN Yan, CHEN Shengyue, HAN Yuanyuan, LYU Zhibo, XU Qing, ZHAO Xin.
Combined Predictive Value of Neutrophil-to-lymphocyte Ratio and Platelet-to-lymphocyte Ratio for In-hospital Mortality Risk in Patients with Acute Myocardial Infarction
[J]. Chinese General Practice, 2023, 26(20): 2482-2487.
|
[6] |
CHANG Junpei, CHEN Lu, WU Tong, ZHAO Xiaoli, DUAN Fangfang, LIU Danna, KONG Tiandong.
Occurrence and Treatment of Endocrinologic Adverse Reactions Associated with Immune Checkpoint Inhibitors: a Single-center Real-world Study
[J]. Chinese General Practice, 2023, 26(17): 2095-2101.
|
[7] |
MA Wanrui, MA Qianfeng, WU Jingjie, WANG Liqun, WANG Zhizhong.
A Ten-year Cohort Study of the Association between Cardiometabolic Risk Factor Cluster and All-cause Mortality Risk among Community-dwelling Aged 55 and Over Adults
[J]. Chinese General Practice, 2023, 26(14): 1703-1708.
|
[8] |
YAO Huijuan, YANG Yu, XU Ajing.
Interpretation of Diabetes Management in Chronic Kidney Disease: a Consensus Report by the American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO)
[J]. Chinese General Practice, 2023, 26(12): 1415-1421.
|
[9] |
YAN Peng, SONG Jianling, FANG Xiangdong.
Recent Developments in Parathyroid Hormone Type 1 Receptor and Kidney Disease
[J]. Chinese General Practice, 2023, 26(11): 1398-1403.
|
[10] |
HU Chunyan, LI Yajing, GENG Tonghui, ZHANG Dongxue.
Protective Effect of Far Infrared Therapy Using HITH-4 Type Apparatus and External Use of Hirudoid for Autogenous Arteriovenous Fistula in Diabetic Dialysis Patients
[J]. Chinese General Practice, 2023, 26(08): 951-954.
|
[11] |
DUAN Zhaohui, ZHANG Min, XU Jieru, XIONG Wenjing, CHEN Lei, ZHAO Xiangling, ZHANG Yiyun, RANG Weiqing.
Past (2000-2019) and Future (2020-2024) Trends of Brain Cancer Mortality in China
[J]. Chinese General Practice, 2023, 26(06): 734-741.
|
[12] |
WU Xiuling, LI Jianjun, YU Ying, XING Rong, WANG Lu, WANG Xuedong, TENG Fubin.
Safety of Weekly Single versus Divided Administration of Moderate-dose Erythropoietin in the Treatment of Maintenance Hemodialysis Patients with Renal Anemia
[J]. Chinese General Practice, 2023, 26(06): 711-717.
|
[13] |
YAO Huihui, SHU Lin, YAO Linli, LI Sha, YANG Xiaotong, LI Yunchun.
Sex-specific Analysis of Influencing Factors for the Association between Baseline Serum Uric Acid and Two-year Outcome after First Acute Ischemic Stroke
[J]. Chinese General Practice, 2023, 26(05): 557-562.
|
[14] |
LIU Linhua, ZHAN Jinfeng, XIA Zhongbin.
Effect of Impaired Fasting Glucose on Estimated Glomerular Filtration Rate
[J]. Chinese General Practice, 2023, 26(03): 304-307.
|
[15] |
SONG Pingan, CHEN Xiaoliang, YAO Yuan, GAO Jin, YANG Yang, CUI Hongchun, ZHANG Yi.
Efficacy and Safety of PD-1 Inhibitors Monotherapy for Elderly Patients with Advanced Non-small Cell Lung Cancer
[J]. Chinese General Practice, 2023, 26(02): 241-247.
|